Results 291 to 300 of about 346,633 (388)
Fundamental Study of Nobel Prize Winners at Cambridge University
, 2006 Shuwen Wang
openalex +2 more sources
Envisioning the Future of Work: From Ideas to Reforms
British Journal of Industrial Relations, EarlyView.ABSTRACT Two different theoretical perspectives concerning technology and the future of work are examined. One is linked to mainstream economics, whereas the other is associated with critical (‘post‐work’) discourse. Ideas about work—its nature and impacts on well‐being—matter in both perspectives.
David A. Spencer
wiley +1 more source
Computers and chess masters: The role of AI in transforming elite human performance
British Journal of Psychology, EarlyView.Abstract Advances in Artificial Intelligence (AI) have made significant strides in recent years, often supplementing rather than replacing human performance. The extent of their assistance at the highest levels of human performance remains unclear. We analyse over 11.6 million decisions of elite chess players, a domain commonly used as a testbed for AI
Merim Bilalić, Mario Graf, Nemanja Vaci
wiley +1 more source
Nobel Prize Team Member To Speak At UNH Undergraduate Research Conference April 23, 2008
, 2008 Jody Record
openalex +1 more source
British Journal of Psychology, EarlyView.Abstract Behavioural science research has the potential to develop evidence‐based strategies to fight disinformation about climate science and climate mitigation action; however, this research has yet to be conducted systematically with validated sets of climate disinformation stimuli. Here, we present the Climate Disinformation Corpus, a collection of
Tobia Spampatti +3 more
wiley +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
British Journal of Pharmacology, EarlyView.Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
It's about time: the heterochronic background for the 2024 Nobel Prize in Physiology or Medicine.
Dis Model MechWightman B.
europepmc +1 more source
Disparities in funding for Nobel Prize awards in medicine and physiology across nationalities, races, and gender. [PDF]
J Cell PhysiolNeikirk K +12 more
europepmc +1 more source